Accelerating Medicines Partnership-Rheumatoid Arthritis (AMP-RA)
Demographics (2)
- age - Subject age (phv00325554.v1.p1)
- sex - Gender of participant (phv00325551.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for rheumatoid arthritis (RA) and lupus (phv00325544.v1.p1)
- age_onset - Disease onset age (phv00325550.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00325552.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00325557.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00325556.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00325541.v1.p1)
- education - Level of education (phv00325553.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00325559.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00325558.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00325555.v1.p1)
- SAMPLE_ID - Sample ID (phv00325546.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00325547.v1.p1)
- SAMPLE_USE - Sample Use (phv00325548.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00325560.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00325543.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00325549.v1.p1)
- SUBJECT_ID - Subject ID (phv00325540.v1.p1)
- SUBJECT_ID - Subject ID (phv00325545.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00325542.v1.p1)